In 2008 Intomics was founded by leading scientists within the fields of bioinformatics and systems biology to accelerate and improve drug discovery and development through optimized utilization of biomedical data. Due to vast experience with a broad range of biomedical data types and a high success rate with disease related research, the founders were convinced that the pharmaceutical industry could benefit from their pioneering research.
Since our foundation, Intomics has helped clients from the pharmaceutical industry with a variety of projects involving bioinformatics and systems biology. Intomics’ services have expanded into new areas within Pharmaceutical Research & Development and Intomics has acquired in-depth knowledge in applying biomedical big data throughout the drug development value chain.
Our focus has always been on establishing close collaborations that fully exploit the synergy between our clients’ specific disease knowledge and our unique capabilities and technological solutions.
In 2017 after years of substantial growth in both clients and employees Intomics established its first US office in Cambridge, Massachusetts .
Mission and Vision
Our mission is to enable the pharmaceutical industry to develop new drug treatments more effectively by using integrative bioinformatics and systems biology technologies
Our vision is to become the leading and most advanced supplier of integrative bioinformatics and systems biology technologies to the pharmaceutical industry
Thomas S. Jensen, PhD, CEO and Co-Founder
Thomas holds an M.Sc. in biological engineering and a PhD in Bioinformatics and Systems Biology. He was the co-founder of the Integrative Systems Biology group at Center of Biological Sequence analysis (CBS) as the Technical University of Denmark. Thomas has extensive experience in leading and managing knowledge-intensive activities and has successfully participated in several life-science projects.
Rasmus Wernersson, CSO, Co-Founder
Rasmus is the Scientific Director at Intomics A/S and holds a position as external Associate Professor of Bioinformatics and Systems Biology at the Technical University of Denmark.
Rasmus has been working with Bioinformatics since the mid 1990s and has a dual background in Molecular Biology (MSc, University of Copenhagen, 1998) and software engineering (IT-D, Copenhagen University College of Engineering, 2006). Rasmus’ current research interests are centered around a network biology oriented approach to biomarker and drug target discovery.
Eske Rygaard-Hjalsted, MSc, VP Sales and BD
Eske has a M.Sc in Molecular Biology from the Technical University of Denmark. He has more than 20 years of commercial expertise in the life science area, with focus on automated cancer diagnostics, companion diagnostics and liquid biopsies. He has extensive experience from CEO and VP-level positions in startups, including 3 life science startups in Silicon Valley (2011-2014). Eske has a successful track record of establishing international partnerships, commercial as well as in the public healthcare sector.